INVO Bioscience, Inc. (NASDAQ:INVO) Sees Large Drop in Short Interest

INVO Bioscience, Inc. (NASDAQ:INVO) was the target of a large decline in short interest in September. As of September 30th, there was short interest totalling 2,000 shares, a decline of 96.6% from the September 15th total of 58,900 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily volume of 174,300 shares, the days-to-cover ratio is currently 0.0 days.

INVO Bioscience Stock Performance

Shares of NASDAQ INVO traded down $0.03 during mid-day trading on Friday, reaching $0.66. The company had a trading volume of 100,919 shares, compared to its average volume of 1,321,656. The company has a 50-day moving average price of $0.77 and a two-hundred day moving average price of $0.87. INVO Bioscience has a 1-year low of $0.50 and a 1-year high of $3.50.

INVO Bioscience (NASDAQ:INVO) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.62) EPS for the quarter. The business had revenue of $1.84 million for the quarter.

INVO Bioscience Company Profile

INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.